Cargando…

Chromogranin A expression in plasma of critically ill patients

Detalles Bibliográficos
Autores principales:	Lavaux, T, Schneider, F, Bach, C, Herbrecht, J-E, Aunis, D, Metz-Boutigue, M-H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254955/ http://dx.doi.org/10.1186/cc9140

Ejemplares similares

Two chromogranin A-derived peptides, chromofungin and catestatin, induce neutrophil activation via a store-operated channel-dependent mechanism
por: Metz-Boutigue, MH, et al.
Publicado: (2010)

A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)
por: Degorce, F, et al.
Publicado: (1999)

Catestatin, an endogenous Chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum
por: Akaddar, Aziza, et al.
Publicado: (2009)

Plasma amino acids in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Urinary and plasma cytokines in the critically ill
por: Adam, Z, et al.
Publicado: (2006)

Two Chromogranin A-Derived Peptides Induce Calcium Entry in Human Neutrophils by Calmodulin-Regulated Calcium Independent Phospholipase A(2)
por: Zhang, Dan, et al.
Publicado: (2009)

Plasma citrulline kinetics and prognostic value in the critically ill patient
por: Piton, G, et al.
Publicado: (2009)

Relationship between plasma NGAL and serum creatinine is influenced by leucocytosis and neutrophilia in the critically ill
por: Glassford, NJ, et al.
Publicado: (2012)

Plasma filtration with dialysis (plasma diafiltration) in critically ill patients with acute liver failure
por: Eguchi, Y, et al.
Publicado: (2014)

Clinical usefulness of measurement of plasma soluble fibrin levels in critically ill patients
por: Masuda, T, et al.
Publicado: (2014)

Differential pathways for the interleukin-1β production activated by chromogranin A and Aβ in microglia
por: Wu, Zhou, et al.
Publicado: (2013)

Expression of glucose transporters in critical illness
por: Langouche, L, et al.
Publicado: (2006)

Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients
por: Wort, S, et al.
Publicado: (2004)

Plasma DNA concentration as an early predictor of outcome in critically ill septic patients
por: El-Akabawy, H, et al.
Publicado: (2011)

Cateslytin, a Chromogranin A Derived Peptide Is Active against Staphylococcus aureus and Resistant to Degradation by Its Proteases
por: Aslam, Rizwan, et al.
Publicado: (2013)

Evaluation of plasma thiolic groups and reactive oxygen metabolites in critically ill patients
por: Montini, L, et al.
Publicado: (2008)

Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care
por: Schneider, Francis, et al.
Publicado: (2022)

Can plasma-free DNA concentration be a diagnostic tool in critically ill septic patients?
por: Orbey, B, et al.
Publicado: (2007)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

A172 THE LACK OF CHROMOGRANIN A PROTECTS THE COLONIC EPITHELIAL BARRIER FUNCTIONS FROM COLITIS IN MALE MICE AND EXACERBATES COLITIS IN FEMALE MICE
por: Tshikudi, D M, et al.
Publicado: (2023)

Influence of Stewart acid–base variables on plasma pH in critically ill patients
por: Marcelli, A, et al.
Publicado: (2008)

Plasma and urine neutrophil gelatinase-associated lipocalin as markers of acute kidney injury in critically ill adults
por: Matsa, R, et al.
Publicado: (2012)

Dysmagnesaemia and Critical Illness Outcomes
por: Homer, LE, et al.
Publicado: (2015)

The Critically Ill Adults scale
por: Schoonderbeek, J, et al.
Publicado: (2005)

Reliability of the HemoCue(® )hemoglobinometer in critically ill patients
por: Frasca, D, et al.
Publicado: (2010)

Corticosteroids for critically ill patients: an international survey of intensivists
por: Lamontagne, F, et al.
Publicado: (2012)

Transfusion from male-only vs female donors in critically ill recipients of high plasma volume components
por: Gajic, O, et al.
Publicado: (2007)

Plasma levels of Coenzyme Q10 are reduced in critically ill patients as compared to healthy volunteers and correlate with age
por: Coppadoro, A, et al.
Publicado: (2012)

Impact of critical illness severity on transfusion requirements
por: Evagelopoulou, P, et al.
Publicado: (2006)

Quality indicators in critically ill patients
por: Martin, M, et al.
Publicado: (2006)

Plasma platelet-derived microparticles to platelet count ratio as a marker of mortality in critically ill patients
por: Ohuchi, M, et al.
Publicado: (2014)

Aberrant bone metabolism in critical illness
por: Vanhees, I, et al.
Publicado: (2012)

Liver transplantation in the critically ill: a Canadian collaboration
por: Karvellas, C, et al.
Publicado: (2012)

The reliability of electrocardiogram interpretation in critically ill patients
por: Lim, W, et al.
Publicado: (2005)

Pseudohyperkalemia during the onset of critical illness
por: Tsolakidis, G, et al.
Publicado: (2004)

Critical illness polyneuropathy: incidence and risk factors
por: Meyer, B, et al.
Publicado: (2006)

Reduction of the catheter-related bloodstream infections in critically ill patients
por: Peredo, R, et al.
Publicado: (2009)

Melatonin blood values and total antioxidant capacity in critically ill patients
por: D'Amato, LA, et al.
Publicado: (2014)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Feasibility of neuromuscular electrical stimulation in critically ill patients
por: Segers, J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hbgllc9keuiea689n6sclll9vn